Education
About Us
Working with TipRanks
Follow Us
Transcenta Holding Limited (HK:6628)
:6628
6628 Stock Chart & Stats
HK$3.57
HK$0.00(0.00%)
At close: 4:00 PM EST
HK$3.57
HK$0.00(0.00%)
Day’s Range― - ―
52-Week RangeHK$0.50 - HK$5.80
Previous CloseN/A
Volume339.50K
Average Volume (3M)1.42M
Market Cap
HK$1.16B
Enterprise ValueHK$713.94M
Total Cash (Recent Filing)HK$45.81M
Total Debt (Recent Filing)HK$210.14M
Price to Earnings (P/E)―
Beta1.06
Next Earnings
Mar 26, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.29
Shares Outstanding452,409,000
10 Day Avg. Volume1,125,950
30 Day Avg. Volume1,421,347
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)0.32
Price to Sales (P/S)21.27
P/FCF Ratio-1.11
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-5.68
Revenue Forecast (FY)HK$101.66M
Transcenta Holding Limited News
6628 FAQ
What was Transcenta Holding Limited’s price range in the past 12 months?
Transcenta Holding Limited lowest stock price was HK$0.50 and its highest was HK$5.80 in the past 12 months.
What is Transcenta Holding Limited’s market cap?
Transcenta Holding Limited’s market cap is HK$1.16B.
When is Transcenta Holding Limited’s upcoming earnings report date?
Transcenta Holding Limited’s upcoming earnings report date is Mar 26, 2026 which is in 120 days.
How were Transcenta Holding Limited’s earnings last quarter?
Transcenta Holding Limited released its earnings results on Aug 27, 2025. The company reported -HK$0.295 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.295.
Is Transcenta Holding Limited overvalued?
According to Wall Street analysts Transcenta Holding Limited’s price is currently Overvalued.
Does Transcenta Holding Limited pay dividends?
Transcenta Holding Limited does not currently pay dividends.
What is Transcenta Holding Limited’s EPS estimate?
Transcenta Holding Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Transcenta Holding Limited have?
Transcenta Holding Limited has 452,409,000 shares outstanding.
What happened to Transcenta Holding Limited’s price movement after its last earnings report?
Transcenta Holding Limited reported an EPS of -HK$0.295 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -8.466%.
Which hedge fund is a major shareholder of Transcenta Holding Limited?
Currently, no hedge funds are holding shares in HK:6628
Transcenta Holding Limited Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
240.25%
12-Months-Change
Fundamentals
Return on Equity
-34.18%
Trailing 12-Months
Asset Growth
-28.12%
Trailing 12-Months
Company Description
Transcenta Holding Limited
Transcenta Holding Limited (6628) is a biopharmaceutical company focused on the discovery, development, and commercialization of innovative biologics for the treatment of cancer and autoimmune diseases. The company operates in the biotechnology sector and specializes in monoclonal antibodies and other biological therapeutics. Its core products include its proprietary drug candidates that target specific pathways involved in disease progression, aiming to provide effective and tailored treatment options for patients.
Technical Analysis
Kintor Pharmaceutical Ltd
―
TOT BIOPHARM International Co. Ltd.
―
Clover Biopharmaceuticals Ltd.
―
Sirnaomics Ltd.
―
SinoMab Bioscience Ltd.
―